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Objective: We analyzed non-small cell lung cancer patient sur-
vival in our single institution database to evaluate the effect of
visceral pleural invasion (VPI) on survival and to propose a
method of incorporating VPI into T-status classification in future
staging systems.
Methods: We reviewed 2725 consecutive surgically resected non-
small cell lung cancer patients with T1a, T1b, T2a, T2b, or T3
tumors for their clinicopathologic characteristics and prognoses.
Visceral pleural invasion was classified using the criteria of the 7th
edition of the TNM Classification for Lung and Pleural Tumors.
Results: There were no significant differences in survival between
PL1 and PL2 patients. Therefore, we decided to combine the PL1
and PL2 patient groups into a single VPI group, and compare
survival with a PL0 (VPI) group to analyze the effect of VPI on T
classification. The best survival was observed in patients with a
T1a/VPI tumor, followed by those with a T1b/VPI tumor. In
comparison, survival was similarly worse among patients with a
T1a/VPI, T1b/VPI, T2a/VPI, or T2b/VPI tumor. The worst
survival was observed in patients with a T2a/VPI, T2b/VPI or
T3 tumor.
Conclusions: Otherwise T2 tumors with VPI, regardless of size,
may be classified as T3 tumors in the next edition of the TNM
Classification for Lung and Pleural Tumors.
Key Words: Visceral pleural invasion, Non-small cell lung cancer,
TNM Classification, T-status.
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Visceral pleural invasion (VPI) by lung cancer is known asa poor prognosvic factor.1–7 In 2004, Shimizu et al. found
no statistically significant difference in survival between
patients with tumor invasion beyond the elastic layer (PL1),
and those with tumor invasion across the pleura with expo-
sure on the pleural surface (PL2), regardless of tumor diam-
eter. They concluded that PL1 and PL2 could be combined to
define VPI,1 which was compatible with the findings by
Osaki et al.6 In contrast, Sakakura et al.8 reported significant
differences in survival between PL1 and PL2 patients, but
they did not describe whether they used elastic stains in
diagnosing VPI status.1,6 In the 7th edition of the TNM
Classification for Lung and Pleural Tumors, VPI is defined as
comprising both PL1 and PL2.9–11
In the TNM Classification, using the VPI definition,
tumors 3 cm or less (T1a and T1b) with VPI are upstaged as
T2a,9,10 whereas tumors greater than 3 and 7cm or less (T2a
and T2b) with VPI remain T2.9,10 Shimizu et al.1 analyzed a
cohort of more than 1600 patients using the same VPI
definition and proposed that a tumor of 3 cm or less with VPI
should remain classified as a T2 tumor, as described in the 6th
edition of the TNM Classification for Lung and Pleural
Tumors, whereas tumors greater than 3 cm with VPI should
be upgraded to T3. In 2009, Yoshida et al.7 analyzed survival
in a large cohort of more than 9700 patients based on a
nation-wide multiinstitutional database and proposed that the
T status of tumors 7 cm or less with VPI should be upgraded
to the next T level. However, their database did not include
details of elastic staining, or how accurately VPI evaluation
was done in each participating institution.
It is still unclear whether PL1 and PL2 are equivalent
and whether they can be combined to define VPI, or how
tumors with VPI should be classified, especially T2 tumors.
We retrospectively analyzed the survival of more than
2700 pulmonary non-small cell lung cancer patients whose
VPI status was evaluated by elastic staining, to evaluate any
PL1 and PL2 equivalence or possible effect of VPI on
T-status classification and survival.
PATIENTS AND METHODS
From January 1979 to December 2006, 2725 consecu-
tive non-small cell lung cancer patients with T classifications
of either T1a, T1b, T2a, T2b, or T3, as defined in the 7th
edition of the TNM Classification for Lung and Pleural
Tumors, underwent complete resection. We defined complete
resection as segmentectomy or greater with systematic ipsi-
lateral hilar and mediastinal lymph node dissection and no
evidence of residual cancer either macroscopically or histo-
logically. Patients who had induction chemotherapy or radio-
therapy, patients with evidence of residual tumor at the
surgical margin, or patients with malignant effusion or distant
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metastasis verified intraoperatively or by means of postoper-
ative pathologic examination were excluded from this study.
In the 7th edition of the TNM Classification for Lung and
Pleural Tumors, a tumor with direct invasion of an adjacent
lobe, either across the fissure or by direct invasion in an area
of fissure defect, is classified as T2a unless other criteria
indicate a higher T category.9,11 During the study period,
however, because there were only 70 tumors with direct
invasion to adjacent lobes, we excluded these patients from
the study. As most pT4 tumors invaded adjacent organs and
were classified as PL3 by definition, it was inappropriate to
include them in comparing the impact of VPI, and they were
excluded from this study.
Cases were pathologically staged based on the 7th
edition of the TNM Classification for Lung and Pleural
Tumors.9 Histopathologic studies were done according to the
World Health Organization criteria,12 and VPI was reviewed
in detail. Tumor sections were stained with hematoxylin and
eosin and Victoria blue-van Gieson stains. VPI was classified
according to the Japan Lung Cancer Society classification of
VPI,13 which is identical to the 7th edition of the TNM
Classification for Lung and Pleural Tumors: PL0 (p0 as
defined by the Japan Lung Cancer Society) is defined as a
tumor within the subpleural lung parenchyma or which in-
vades superficially into the pleural connective tissue beneath
the elastic layer; PL1 (p1) is defined as a tumor that invades
beyond the elastic layer; PL2 (p2) is defined as a tumor that
invades the pleural surface; and PL3 (p3) is defined as a
tumor that invades any component of the parietal pleura.
Overall survival was estimated using the Kaplan-Meier
method, and differences in survival were determined by
log-rank analysis. Zero time was the date of pulmonary
resection, and the end point was defined as the date of death
from any cause. The last follow-up observation was censored
when the patient was alive or lost to follow-up. All p values
were two-sided and p values less than 0.05 were considered
statistically significant. We planned to compare survival be-
tween PL1 and PL2 patients and, if there were no significant
differences in survival between them, to combine the PL1 and
PL2 groups into one VPI group. If VPI was confirmed by
multivariate analyses using the Cox proportional hazards
model, to be independently prognostic among other factors
including gender (man versus woman), histologic type (ade-
nocarcinoma versus nonadenocarcinoma), pathologic T clas-
sification (T1 versus T2), and pathologic N classification (N0
versus N12), we planned to analyze the relative effect of
VPI status on T classification.
Data collection and analyses were approved, and the
need to obtain written informed consent from each patient in
this retrospective study was waived by the institutional re-
view board in January 2010.
RESULTS
Patient Characteristics and VPI
Table 1 shows the patient characteristics. There were
1762 men and 963 women aged 22 to 90 years (median, 66
years). More than 90% of all patients underwent lobec-
tomy including bilobectomy. Adenocarcinoma was the
major histologic type (64%), and more than 70% had no
node involvement.
Survival Difference
The overall survival curves of PL0, PL1, PL2, and T3
patients are shown in Figure 1. The differences in survival
were statistically significant (p  0.001) between PL0 and
PL1, PL0 and PL2, PL0 and T3, and PL1 and T3. In contrast,
the differences in survival were not statistically significant
between PL1 and PL2 (p  0.114) or PL2 and T3 (p 
0.085). We decided to combine the PL1 and PL2 patient
groups into VPI group and compare survival with a PL0
(VPI) group in the following analyses.
The results of multivariate analyses of VPI, gender,
histologic type, pathologic T classification, and pathologic N
classification, as prognostic factors are shown in Table 2. VPI
status proved to be independently prognostic (HR 1.531, p 
0.001), and we analyzed the relative effect of VPI status on T
classification.
According to the tumor diameter (2 cm; T1a, 2.1–3 cm;
T1b, 3.1–5 cm; T2a, or 5.1–7 cm; T2b), VPI status ( or ),
and T3 factor, we divided all patients into nine groups. The
overall 5-year survival rates for nine groups and their survival
curves are shown in Figure 2. The differences in survival
between T1a/VPI and T1b/VPI, T1b/VPI and T1a/VPI,
T1b/VPI and T1b/VPI, T1b/VPI and T2a/VPI, T1b/
VPI and T2b/VPI, T1b/VPI and T2a/VPI, T1b/VPI
and T2b/VPI, T1b/VPI and T3, T2a/VPI and T2b/VPI,
T2b/VPI and T2b/VPI, and T2b/VPI and T3 were statis-
tically significant. However, the differences in survival were not
statistically significant between T1a/VPI and T1b/VPI, T1a/
VPI and T2a/VPI, T1a/VPI and T2b/VPI, T1b/VPI
and T2a/VPI, T1b/VPI and T2b/VPI, T2a/VPI and
T2b/VPI, T2a/VPI and T2b/VPI, T2a/VPI and T3, and
T2b/VPI and T3. Therefore, we were able to stratify the nine
groups into four categories: (1) T1a/VPI, (2) T1b/VPI, (3)
T1a/VPI, T1b/VPI, T2a/VPI, and T2b/VPI, and (4)
T2a/VPI, T2b/VPI, and T3, in decreasing order of survival.
DISCUSSION
In the 7th edition of the TNM Classification for Lung
and Pleural Tumors, the extent of VPI is classified into four
groups (PL0, PL1, PL2, and PL3).9,11 PL1 and PL2 are
combined to define VPI, in the presence of which T1 tumors
are upstaged to T2a.
On the basis of a cohort of more than 1600 patients,
Shimizu et al. found no statistically significant differences in
survival between PL1 and PL2 patients, regardless of tumor
diameter. They concluded that PL1 and PL2 can be combined
to define VPI,1 which was compatible with the findings of
Osaki et al.6 In contrast, Sakakura et al.8 reported significant
differences in survival between PL1 and PL2 patients, but
they did not describe whether they used elastic stains in
diagnosing VPI status.1,6 In our series, there were no statis-
tically significant differences in survival between PL1 and
PL2 patients. We combined PL1 and PL2 patients into a
VPI group, and confirmed VPI to be an independent
unfavorable prognostic factor by multivariate analyses. This
supports the conclusion by Shimizu et al. and Osaki et al. and
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is in accordance with the VPI definition in the 7th edition of
the TNM Classification for Lung and Pleural Tumors.1,6,9
Shimizu et al.1 proposed otherwise T1 and T2 tumors
with VPI should be classified as T2 and T3, respectively, in
the 6th edition of TNM Classification for Lung and Pleural
Tumors. Similarly, using the 7th edition, Yoshida et al.7
proposed the T status of tumors 7 cm or less with VPI should
be upgraded to the next T level, which was compatible with
the conclusion of Shim et al.14
When we analyzed VPI effect on T-status classifica-
tion in our series, the best survival was observed in
patients with a VPI tumor 2 cm or less (T1a), followed
by those with a VPI tumor of 2.1 to 3 cm (T1b). In
comparison, survival was sioilarly worse in patients with a
TABLE 1. Patient Characteristics
Characteristics
VPI Factor of T1/T2 Cases
T3 TotalPL0 PL1 PL2
Age (yrs), median (range) 65 (22–90) 67 (36–89) 65 (22–85) 66 (25–83) 66 (22–90)
Gender
Man 1030 (61) 277 (66) 93 (62) 362 (78) 1762 (65)
Woman 663 (39) 140 (34) 57 (38) 103 (22) 963 (35)
Surgery
Segmentectomy 41 (2) 6 (1) 0 (0) 5 (1) 52 (2)
Lobectomy 1606 (95) 397 (95) 147 (98) 381 (82) 2531 (93)
Pneumonectomy 46 (3) 14 (3) 3 (2) 79 (17) 142 (5)
Histology
Adenocarcinoma 1132 (67) 257 (62) 121 (81) 234 (50) 1744 (64)
Squamous cell carcinoma 423 (25) 109 (26) 19 (13) 160 (34) 711 (26)
Adenosquamous carcinoma 25 (1) 13 (3) 1 (1) 25 (5) 64 (2)
Large cell carcinoma 35 (2) 14 (3) 3 (2) 20 (4) 72 (3)
Others 78 (5) 24 (6) 6 (4) 26 (6) 134 (5)
Tumor diameter (cm)
2 595 (35) 73 (18) 12 (8) 6 (1) 686 (25)
2.1–3 530 (31) 106 (25) 53 (35) 31 (7) 720 (26)
3.1–5 476 (28) 173 (41) 70 (47) 94 (20) 813 (30)
5.1–7 92 (5) 65 (16) 15 (10) 73 (16) 245 (9)
7.1 — — — 261 (56) 261 (10)
Pathological N classification
N0 1364 (81) 275 (66) 82 (55) 205 (44) 1926 (71)
N1 185 (11) 66 (16) 28 (19) 126 (27) 405 (15)
N2 144 (9) 76 (18) 40 (27) 134 (29) 394 (14)
Total 1693 417 150 465 2725
Data are given as n (%).
VPI, visceral pleural invasion (VPI status as defined by the 7th edition of the TNM Classification for Lung and Pleural Tumours); N0,
No regional lymph node metastases; N1, Metastases to ipsilateral peribronchial and/or hilar lymph nodes, and intrapulmonary nodes including
involvement by direct extension of the primary tumor; N2, Metastases to ipsilateral mediastinal and/or subcarinal lymph nodes.
FIGURE 1. Overall survival curves of PL0, PL1, PL2, and T3
patients.
TABLE 2. Multivariate Analyses of Overall Survival
Characteristics
Hazard Ratio
(95% CI) p
Gender (man versus woman) 1.502 (1.270–1.776) 0.001
Histology (non-adenocarcinoma
versus adenocarcinoma)
1.283 (1.099–1.499) 0.002
Pathological T classification
(T2 versus T1)
1.844 (1.583–2.147) 0.001
Pathological N classification
(N12 versus N0)
2.576 (2.218–2.990) 0.001
VPI (present versus absent) 1.531 (1.316–1.780) 0.001
VPI, visceral pleural invasion.
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T1a/VPI tumor, T1b/VPI tumor, VPI tumor of 3.1 to
5 cm (T2a), or VPI tumor of 5.1 to 7 cm (T2b). These
results suggest that otherwise T1a and T1b tumors with
VPI should be upstaged to T2. However, there was no
significant difference in survival between patients with a T2a/
VPI tumor and those with a T2b/VPI tumor. It was unclear
whether T1a and T1b tumors with VPI should be further clas-
sified as either T2a or T2b.
FIGURE 2. A, All survival curves stratified by tumor size and VPI status. B, Survival curves of T1a/VPI and T1b/VPI. C, Sur-
vival curves of T1b/VPI, T1a/VPI and T2a/VPI. D, Survival curves of T1a/VPI, T1b/VPI, T2a/VPI, and T2b/VPI. E,
Survival curves of T1b/VPI, T2b/VPI, T2a/VPI, T2b/VPI and T3. VPI, visceral pleural invasion.
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The worst survival was observed among patients with a
T2a/VPI tumor, T2b/VPI tumor, or a T3 tumor. These
results suggest that otherwise T2 tumors with VPI, regardless
of size, should be upstaged to T3. These suggestions are
summarized as our proposal in Table 3.
It is not clear why VPI is associated with a worse
outcome. In our cohort, nodal metastases were significantly
more frequent in patients with VPI than in those without VPI
in each tumor size group (p  0.001, 2 test). This supports
the suggestion by Shimizu et al.1 that there is a possible VPI
tumor cell pathway through the subpleural lymphatics, hilar
lymph nodes, and the mediastinal lymph nodes. We also
analyzed only pN0 patients to exclude confounding effects
with lymph node involvement, but survival curves did not
estrange each other as clearly as in the entire cohort. This
may be because of the small number of patients in each
subgroup.
Although this study is retrospective, it included a large
number of patients, and evaluated VPI status in all patients
with elastic stains. However, proposals on how to incorporate
VPI status into the T classification vary. Therefore, we need
to collect more VPI data internationally and accurately using
elastic stains, based on the 7th edition of the TNM Classifi-
cation for Lung and Pleural Tumors, in cooperation with the
International Association for the Study of Lung Cancer.
In conclusion, this study indicates that PL1 and PL2
status are mostly equivalent and can be combined within the
category of VPI. Otherwise T2 tumors with VPI, regardless
of size, may be classified as T3 in the next edition of the TNM
Classification for Lung and Pleural Tumors.
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TABLE 3. T Classification Comparison
Group
Tumor
Diameter (cm)
VPI
Status
7th Edition T
Classification
Our
Proposal
1 2  T1a T1a
2 2  T2a T2(a)
3 2.1–3  T1b T1b
4 2.1–3  T2a T2(a)
5 3.1–5  T2a T2a
6 3.1–5  T2a T3
7 5.1–7  T2b T2b
8 5.1–7  T2b T3
VPI  PL0, VPI  PL1 or PL2.
VPI, visceral pleural invasion.
T classifications in bold in our proposal differ from those in the 7th edition T
classification.
Kawase et al. Journal of Thoracic Oncology • Volume 5, Number 11, November 2010
Copyright © 2010 by the International Association for the Study of Lung Cancer1788
